Work

Correction

Year: 2021
Type: erratum
Abstract: In an article1 titled “Benefit-risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers” by Di Bei, Mayu Osawa, Shinji Uemura, Tomoya Ohno, Jogarao Gobburu, Amit Roy, Mayumi Hasegawa, the authors would like to correct the description under section 2.4 in Materials and Methods. The sentence “E-R models of OS and ORR that included 1749 and 1710 patients, respectively, now included 134 Japanese patients from regional studies.” should read as “E-R models of OS and ORR that included 1749 patients, now included 134 Japanese patients from regional studies.” The authors apologize for the error.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,600
OpenAlex ID: W4206347518
Cites: 1
Cited by:
Related to: 8